Outset Medical, Inc. OM
Set alert
4.03 USD -0.16 -3.82%
At close · Oct 30
4.03 0.00 0.00%
After hours · Oct 30, 4:00 PM ET
3.90 Day range 4.15
2.96 52-week range 13.12
- YTD
- +8.63%
- 1 year
- -68.09%
- Open
- 4.02
- Prev close
- 4.19
- Mkt cap
- 75.75M
- Vol
- 81.50K
- Avg vol
- 152.47K
- EPS
- -4.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 3.90
- High
- 4.15
- Forward P/E
- -0.89
- Beta
- 1.95
- Short ratio
- 2.94
- Inst. own
- 52.16%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 7, 2024
- 50-d avg
- 0.82834
- 200-d avg
- 2.07
- 1y target
- 4.00
6M chart
Signals (48)
| Name | Date | Ago |
|---|---|---|
| SMA: Bearish | Oct 30, 2026 | 1 day ago |
| SMA: Bullish | Oct 27, 2026 | 4 days ago |
| SMA: Bearish | Oct 21, 2026 | 1 week ago |
| SMA: Bullish | Oct 20, 2026 | 1 week ago |
| SMA: Bullish | Oct 15, 2026 | 2 weeks ago |
| SMA: Bearish | Oct 14, 2026 | 2 weeks ago |
| SMA: Bearish | Oct 8, 2026 | 3 weeks ago |
| SMA: Bullish | Oct 7, 2026 | 3 weeks ago |
| SMA: Bullish | Oct 2, 2026 | 4 weeks ago |
| RSI: Oversold | Sep 28, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 22, 2026 | 1 month ago |
| RSI: Oversold | Sep 9, 2026 | 1 month ago |
| SMA: Bearish | Aug 18, 2026 | 2 months ago |
| SMA: Bullish | Aug 14, 2026 | 2 months ago |
| SMA: Bearish | Aug 13, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 13, 2026 | 2 months ago |
| SMA: Bearish | Aug 12, 2026 | 2 months ago |
| SMA: Bullish | Jul 28, 2026 | 3 months ago |
| MACD: Buy Signal | Jul 28, 2026 | 3 months ago |
| SMA: Bullish | Jul 27, 2026 | 3 months ago |
| SMA: Bearish | Jul 24, 2026 | 3 months ago |
| SMA: Bullish | Jul 23, 2026 | 3 months ago |
| SMA: Bearish | Jul 20, 2026 | 3 months ago |
| SMA: Bearish | Jul 16, 2026 | 3 months ago |
| SMA: Bullish | Jul 14, 2026 | 3 months ago |
| SMA: Bearish | Jul 10, 2026 | 3 months ago |
| SMA: Bullish | Jul 9, 2026 | 3 months ago |
| SMA: Bearish | Jul 8, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 8, 2026 | 3 months ago |
| SMA: Bullish | Jul 1, 2026 | 4 months ago |
| MACD: Buy Signal | Jul 1, 2026 | 4 months ago |
| SMA: Bearish | Jun 29, 2026 | 4 months ago |
| MACD: Sell Signal | Jun 26, 2026 | 4 months ago |
| MACD: Buy Signal | Jun 22, 2026 | 4 months ago |
| SMA: Bullish | Jun 18, 2026 | 4 months ago |
| SMA: Bullish | Jun 18, 2026 | 4 months ago |
| SMA: Bearish | Jun 17, 2026 | 4 months ago |
| SMA: Bearish | Jun 17, 2026 | 4 months ago |
| SMA: Bullish | Jun 16, 2026 | 4 months ago |
| SMA: Bearish | Jun 15, 2026 | 4 months ago |
| SMA: Bullish | Jun 12, 2026 | 4 months ago |
| SMA: Bearish | Jun 11, 2026 | 4 months ago |
| MACD: Sell Signal | Jun 10, 2026 | 4 months ago |
| MACD: Buy Signal | May 22, 2026 | 5 months ago |
| SMA: Bullish | May 20, 2026 | 5 months ago |
| SMA: Bullish | May 20, 2026 | 5 months ago |
| SMA: Bearish | May 8, 2026 | 5 months ago |
| SMA: Bearish | May 8, 2026 | 5 months ago |
Key statistics
- Market cap
- 62.00M
- Enterprise value
- 90.03M
- Trailing P/E
- 0.00
- Forward P/E
- -0.89
- PEG ratio
- 0.00
- Price / sales
- 0.54
- Price / book
- 1.30
- EPS (TTM)
- -2.74
- Beta
- 1.95
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- -122.84%
- Revenue (TTM)
- 114.73M
- Revenue growth
- -5.60%
- Free cash flow
- -77.26M
- Total cash
- 175.63M
- Total debt
- 202.08M
- Return on equity
- -141.02%
- Shares outstanding
- 52.54M
- Short % of float
- 6.22%
- 50-day average
- 0.82834
- 200-day average
- 2.07
Analyst view
Consensus: buy
Buy
Price target (mean) 4.00 -0.7% downside
Now 4.03
- Target (low)
- 3.00
- Target (mean)
- 4.00
- Target (high)
- 6.00
Ratings (0m) 5 3 buy · 2 hold · 0 sell
- Strong buy0
- Buy3
- Hold2
- Sell0
- Strong sell0
Next earnings
Aug 7, 2024
Expected Aug 7, 2024. Consensus EPS estimate -0.405.
Financials — quick view
OM Revenue — quarterly 31.64M
OM Net income — quarterly -17.98M
OM EPS — quarterly -0.97
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 6, 2024 | Sep 1, 2024 | -0.42 | -0.39 | +0.03 | +7.14% |
| Aug 7, 2024 | Jun 1, 2024 | -0.43 | -0.47 | -0.04 | -9.30% |
| Aug 7, 2024 | Jun 1, 2024 | -0.43 | — | — | — |
| May 8, 2024 | Mar 1, 2024 | -0.53 | -0.57 | -0.04 | -7.55% |
| May 8, 2024 | Mar 1, 2024 | -0.53 | — | — | — |
| Feb 21, 2024 | Dec 1, 2023 | -0.61 | — | — | — |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 8, 2024 | RBC Capital | down | Outperform | Sector Perform |
| Aug 8, 2024 | TD Cowen | main | Buy | Buy |
| Jun 21, 2024 | RBC Capital | up | Sector Perform | Outperform |
| Apr 8, 2024 | BTIG | init | — | Buy |
| Jan 12, 2024 | RBC Capital | down | Outperform | Sector Perform |
| Dec 4, 2023 | Morgan Stanley | main | Equal-Weight | Equal-Weight |
About Outset Medical, Inc.
Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company offers Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables. It also provides Tablo Data Ecosystem, including TabloHub, a customer-facing portal; MyTablo, a patient-facing portal; and TabloDash, an internal data analytics platform. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.
- Sector
- Healthcare
- Industry
- Medical Devices
- Country
- United States
- Website
- outsetmedical.com
News
Your note
Sign in to keep a note on OM — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| AHMED NABEEL | Chief Financial Officer | Sale | Nov 14, 2024 | 310,767 |
| BROTTEM JOHN L. | General Counsel | Sale | Nov 14, 2024 | 227,092 |
| DREXLER KAREN | Director | Stock Award(Grant) | May 28, 2024 | 48,232 |
| GROSSMAN DONALD KEITH | Director | Conversion of Exercise of derivative security | Jun 2, 2024 | 79,221 |
| HACKETT PATRICK T. | Director | Stock Award(Grant) | May 28, 2024 | 42,849 |
| HINRICHS JAMES F | Director | Stock Award(Grant) | May 28, 2024 | 80,349 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| FMR, LLC | 9.09% | 4,773,776 | 5.63M | Sep 29, 2024 |
| Vanguard Group Inc | 5.03% | 2,644,534 | 3.12M | Sep 29, 2024 |
| Millennium Management Llc | 3.59% | 1,888,424 | 2.23M | Sep 29, 2024 |
| Ameriprise Financial, Inc. | 3.45% | 1,810,234 | 2.14M | Sep 29, 2024 |
| GMT Capital Corp | 2.80% | 1,471,706 | 1.74M | Sep 29, 2024 |
| Mubadala Investment Co PJSC | 2.74% | 1,440,601 | 1.70M | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Fidelity Select Portfolios - Medical Technology & Devices Port | 6.28% | 3,300,000 | 3.89M | Oct 30, 2024 |
| Vanguard Total Stock Market Index Fund | 3.14% | 1,647,932 | 1.94M | Sep 29, 2024 |
| Vanguard Extended Market Index Fund | 1.43% | 753,842 | 889.53K | Sep 29, 2024 |
| Fidelity Extended Market Index Fund | 0.56% | 293,310 | 346.11K | Oct 30, 2024 |
| Schwab Strategic Tr-Schwab U.S. Small Cap ETF | 0.45% | 238,407 | 281.32K | Aug 30, 2024 |
| Morgan Stanley Inst Fund Inc-Inception Port | 0.37% | 196,183 | 231.50K | Sep 29, 2024 |